RegulatoryOfficial

ANSM amends French directory of generic groups in decision dated 22 October 2026

🇫🇷 ANSM · Wed 28 Oct 2026

The French medicines agency published the decision on 28 October; the notice does not say which generic groups or products are affected.

France's medicines agency, ANSM, has published a decision dated 22 October 2026 that amends the directory of generic groups. The directory is provided for under Article R. 5121-5 of the French Public Health Code. The decision was posted on the agency's website on 28 October 2026.

The web notice does not list the groups or products concerned. It links to a downloadable decision, which holds the detail of the changes, and to the directory of generic medicines.

The notice repeats a procedural point. Since decree 2016-183 of 23 February 2016, published in the Journal officiel on 25 February 2016, publication on the ANSM website has replaced publication in the Journal officiel for decisions that add to or amend the directory.

The notice also says that substitution of the generic medicines named in such decisions may take place only after the decision has been published on the site. On that basis, the 28 October 2026 publication is the point from which substitution can proceed for any products covered by this decision.

What it means for your team

  • Regulatory and market-access teams should download the full decision of 22 October 2026 to see which generic groups or products are affected.
  • Teams should note that substitution under the decision may begin only after its publication on the ANSM site, which here was 28 October 2026.
  • Companies should check the updated directory of generic medicines to see how their products are listed and what this means for their market positioning.

Official source: ANSM ↗

Article written by VigiEye from the official source (ANSM). AI-assisted; check the source before acting.

More Regulatory All →